CN101480210B - Safflower tea drink and preparation method thereof - Google Patents
Safflower tea drink and preparation method thereof Download PDFInfo
- Publication number
- CN101480210B CN101480210B CN200810000602A CN200810000602A CN101480210B CN 101480210 B CN101480210 B CN 101480210B CN 200810000602 A CN200810000602 A CN 200810000602A CN 200810000602 A CN200810000602 A CN 200810000602A CN 101480210 B CN101480210 B CN 101480210B
- Authority
- CN
- China
- Prior art keywords
- safflower
- sterilization
- lixiviate
- tea
- black tea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000003255 Carthamus tinctorius Nutrition 0.000 title claims abstract description 62
- 244000020518 Carthamus tinctorius Species 0.000 title claims abstract description 62
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims description 7
- 230000001954 sterilising effect Effects 0.000 claims abstract description 51
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 30
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 19
- 238000001914 filtration Methods 0.000 claims abstract description 11
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 claims abstract description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 10
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 10
- 229940085605 saccharin sodium Drugs 0.000 claims abstract description 10
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 10
- 239000011718 vitamin C Substances 0.000 claims abstract description 10
- 239000004615 ingredient Substances 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 43
- 238000004659 sterilization and disinfection Methods 0.000 claims description 37
- 235000006468 Thea sinensis Nutrition 0.000 claims description 23
- 235000020279 black tea Nutrition 0.000 claims description 23
- 235000013616 tea Nutrition 0.000 claims description 15
- 238000007789 sealing Methods 0.000 claims description 11
- 239000011265 semifinished product Substances 0.000 claims description 10
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 9
- 229960004998 acesulfame potassium Drugs 0.000 claims description 9
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 9
- 239000000619 acesulfame-K Substances 0.000 claims description 9
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 claims description 9
- 238000011049 filling Methods 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 238000002386 leaching Methods 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 5
- 239000011148 porous material Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 238000012859 sterile filling Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 238000007689 inspection Methods 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 2
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 235000013361 beverage Nutrition 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 208000002193 Pain Diseases 0.000 abstract description 2
- 230000035622 drinking Effects 0.000 abstract description 2
- 230000002175 menstrual effect Effects 0.000 abstract description 2
- 230000028327 secretion Effects 0.000 abstract description 2
- 230000004913 activation Effects 0.000 abstract 2
- 230000002349 favourable effect Effects 0.000 abstract 2
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 abstract 1
- 229960005164 acesulfame Drugs 0.000 abstract 1
- 229960004106 citric acid Drugs 0.000 abstract 1
- 235000015165 citric acid Nutrition 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000003020 moisturizing effect Effects 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
- 229960001790 sodium citrate Drugs 0.000 abstract 1
- 235000011083 sodium citrates Nutrition 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 11
- 238000001223 reverse osmosis Methods 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- 238000005086 pumping Methods 0.000 description 3
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 2
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine group Chemical group [C@@H]1([C@H](O)[C@H](O)[C@@H](CO)O1)N1C=NC=2C(N)=NC=NC12 OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 208000030172 endocrine system disease Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229940119485 safflower extract Drugs 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 1
- 206010008617 Cholecystitis chronic Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000003945 NF-kappa B Human genes 0.000 description 1
- 108010057466 NF-kappa B Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 108090000279 Peptidyltransferases Proteins 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000439 acute liver injury Toxicity 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000000496 anti-anoxic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001740 anti-invasion Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000008557 oxygen metabolism Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008327 renal blood flow Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 201000002282 venous insufficiency Diseases 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
Landscapes
- Non-Alcoholic Beverages (AREA)
Abstract
The invention relates to a safflower tea and a method for preparing the safflower tea, which belong to the field of beverages. Safflower is originated in Xinjiang, has the functions of blood circulation activation, dryness moisturizing, pain relief, detumescence, menstrual flow stimulation, and the like and is favorable for modern staff members to eliminate fatigue, strengthen physical fitness and improve immunity. The method for preparing the safflower tea comprises the following steps: extracting effective ingredients of safflower and safflower powder in a formula of the disclosed safflower tea; adding the following auxiliary materials: white granulated sugar, citric acid, sodium citrate, saccharin sodium, acesulfame and vitamin C; filtering and sterilizing the mixture, and the like. The safflower tea has the advantages of blood circulation activation of human bodies, internal secretion adjustment, colored patch removal, fatigue overcoming, and the like and is also favorable to the development of special products and economy in northwest China. The invention also has the advantages of simple manufacture, convenient drinking and low cost.
Description
Technical field
The present invention relates to field of beverage.
Background technology
Safflower has another name called Huang Lan, red orchid, safflower, safflower dish, and the composite family safflower belongs to the annual herb plant.Safflower originates in Egyptian; Import China during Han dynasty into, the Shanxi has such record for Zhang Huazhu " natural science will " to safflower: " open and to hold high up to such an extent that plant in the Western Regions, also plant it to modern Wei "; All there is distribution in more than 60 country in the whole world now, is the best to produce in the safflower quality in Chinese Xinjiang wherein.Li Shizhen (1518-1593 A.D.) is shown in the Compendium of Material Medica and to be claimed that safflower can " invigorate blood circulation, moisturize, pain relieving, loose and swell, stimulate the menstrual flow ", and the effect of kardiseed is identical with safflower, not only can be used as medicinally, but also can be used as oil plant extraction edible oil.Spending of safflower can be used as medicine, have promoting blood circulation and removing blood stasis, the coronary artery dilator flow, therefore the mediation microcirculation improves the effect of myocardial ischemia, is widely used in treating in the medicine of coronary heart disease, angina pectoris, miocardial infarction.
Modern job the personage under high pressure work for a long time, makes people's mood unhappiness, thought slowness, is the performance of especially big cerebral anoxia in the human body, makes defence capability decline in the body, very easily receives the infringement of virus to cause various diseases.Hoping has a kind of health drink, can strengthen the immunologic function of cell after taking, strengthening body resistance.
Soaked with safflower is that a kind of elimination is tired, constitutional up-and-coming beverage as beverage, receives modern job personage and the elderly's favor surely.
Summary of the invention
The object of the invention can effectively be eliminated fatigue for providing a kind of, build up health, improves health conditions, and the safflower tea of low price, taking convenience and preparation method thereof.
The technical scheme that realizes the foregoing invention purpose is following:
Safflower tea and preparation method thereof, its weight proportion of safflower tea prescription is following:
100 parts in water, white granulated sugar 3-5 part, black tea powder 0.2-0.4 part, safflower 0.4-0.6 part, citric acid 0.1-0.3 part, natrium citricum 0.04-0.06 part, saccharin sodium 0.006-0.009 part, acesulfame potassium 0.01-0.02 part, vitamin C 0.01-0.02 part.
Preferred its weight proportion of safflower tea prescription is following:
100 parts in water, 4 parts of white granulated sugars, 0.3 part of black tea powder, 0.5 part on safflower, 0.2 part of citric acid, 0.05 part of natrium citricum, 0.008 part of saccharin sodium, 0.015 part of acesulfame potassium, 0.015 part of vitamin C.
The preparation process of safflower tea is following:
(1) lixiviate of raw material:
The leaching of safflower effective ingredients: with the purchase safflower suede carry out selected after, put into the lixiviate jar, add the pure water of total water amount 1/2 again; The hot water lixiviate, the hot water temperature is 75-85 ℃, time 60-80min; The lixiviate of black tea active ingredient: with black tea powder or the instant black tea powder of buying carry out selected after, put into the lixiviate jar, add purified water remainder again; The hot water lixiviate, the hot water temperature is 75-85 ℃, time 20-30min;
(2) allotment:
Safflower suede, black tea powder liquid and white granulated sugar, citric acid, natrium citricum, saccharin sodium, acesulfame potassium, vitamin C that lixiviate is good join in the blend tank, stir;
(3) filter:
After the semi-finished product that allotment is good filtered through diatomite filter, after filtering with Membrane filtering machine, pore size filter was 0.1-0.5um again, and is temporary by being pumped in the surge tank;
(4) sterilization:
Semi-finished product in the surge tank are sterilized through being pumped in the sterilizer, and bottle washing machine is to the cleaning and sterilizing of bottle;
(5) filling and sealing:
Carry out sterile filling and seal, 82-90 ℃ of can temperature;
(6) back sterilization cooling
85 ℃ of sterilization temperatures, chilling temperature are 25-30 ℃;
(7) test package:
The cooled product of sterilization through the lamp inspection, is packed warehouse-in.
With the safflower tea of method for preparing, can reduce the blood pressure of anesthetized animal through evidence, and can keep the long period.Safflower extract has excitation to breathing; Under the condition of normobaric hypoxia, can increase the growing amount of pyruvic acid, improve lactic acid dehydrogenase activity in the cardiac muscle cell; Thereby can strengthen intracellular oxygen metabolism function; Improve the hypoxia-bearing capability of heart, weaken strenuous exercise to a certain extent, heart is had certain protective role damage of myocardial cells.Water hot extraction's thing of safflower has the obvious suppression effect to blood clotting; Its active ingredient is adenosine; Can prolong the rise time and the soak time of factor; Suppress the platelet aggregation that adenosine diphosphate (ADP) and collagen cause, quicken the fiber-reactive of urokinase and plasmase, reduce the whole blood specific viscosity.Safflower promotes the secretion and the drainage of bile through improving microcirculation, thereby reduces globulin and the total bilirubin that increases unusually, can be used for the treatment of cirrhosis behind the chronic viral hepatitis.Safflower acid has the chemoprophylaxis effect to the early stage acute liver injury that noxious material causes, it can improve the concentration of glutathione in the cell liquid, strengthens the activity of glutathione S transpeptidase and glutathione peroxidase, is hopeful to be used for the treatment of chronic cholecystitis.
Safflower plays the synthetic important function of TXA2 that suppresses Cycloxygenase, reduces one of prostaglandin family, thereby capillary of kidney is kept clear, and increases renal blood flow, helps the absorption of immune complex, promotes the reparation of inflammation damnification.
The proteoglycan that extracts in the safflower is PKC and NF-kappa B rapidly, promotes the activity of macrophage, thereby has immunological regulation and anti-invasion function.
Safflower extract particularly carthamin can effectively suppress the activity of oxygen radical and xanthine oxidase, shows the antioxidation biology activity.
Safflower has clear and definite pharmacodynamics effect at aspects such as treatment or prevention cardiovascular and cerebrovascular disease and cancers.Particularly safflower has the active anticancer and the hypotoxicity of wide spectrum.
The present invention has following beneficial effect:
1, safflower tea can in time promote the blood oxygen supply of blood of human body circulation, lets drinking person keep resourceful, phychology balance, and is confident, sets up, and improves health conditions enhancing human immune.
2, the endocrine pigment precipitates in skin surface, is caused by endocrinopathy.Safflower tea can in time be regulated endocrine; The color spot that elimination causes because of endocrinopathy, the beauty treatment skin makeup, modern female is because of bearing huge work and life stress; Cause anxiety, uneasiness, sleep quality reduction, blood viscosity to increase easily; The invisible capillary of naked eyes is silted up, and VPV slows down, and makes the skin anoxic.Can be when serious because of hypostasis, pigementation, moisture is extruded blood vessel, causes skin to lose natural gloss because of anoxic, and the spot of pigementation appears in skin surface, drinks the effect that safflower tea can be brought into play its anti-anoxic of invigorating blood circulation to greatest extent, eliminates color spot.
3, the NORTHWEST CHINA wide geographic area all has the safflower growth, develops it as valuable industrial crops, will play useful effect for the lifting of NORTHWEST CHINA regional economy.
4, the present invention makes simply, cost is low, drink conveniently, help popularization.
The specific embodiment
Embodiment 1
1, the lixiviate of raw material:
1.1 the leaching of safflower effective ingredients: with the safflower suede of purchase carry out selected after, take by weighing 0.5 part and put into the lixiviate jar, add again through 50 parts of the pure water of reverse osmosis water treating equipment, the hot water lixiviate, the hot water temperature is 75-85 ℃, time 60min.
1.2 the lixiviate of black tea active ingredient: with the black tea powder (or instant black tea powder) of buying carry out selected after, take by weighing 0.3 part and put into the lixiviate jar, add again through 50 parts of the pure water of reverse osmosis water treating equipment, the hot water lixiviate, the hot water temperature is 75-85 ℃, time 20min.
2, allotment:
The safflower suede that lixiviate is good, black tea powder liquid and 4 parts of white granulated sugars, 0.2 part of citric acid, 0.05 part of natrium citricum, 0.008 part of saccharin sodium, 0.015 part of acesulfame potassium, vitamin C join in the blend tank for 0.015 part, stir.
3, filter:
After the semi-finished product that allotment is good filtered through diatomite filter, after filtering with Membrane filtering machine, pore size filter was 0.2um again, sends in the surge tank temporary by centrifugal pump.
4, sterilization:
Semi-finished product in the surge tank are gone in the ultra high temperature short time sterilization device to sterilize 120 ℃ of sterilising temps, sterilization time 4s through centrifugal pumping.
5, the sterilization of bottle and lid:
With bottle washing machine bottle and bottle cap are carried out cleaning and sterilizing.
6, filling and sealing:
Adopt WTRO-1 type sterile filling sealing device to carry out filling and sealing, 82 ℃ of can temperature.
7, back sterilization cooling:
Cool off through sterilization behind the fountain sterilization machine again through the product after the can, 85 ℃ of sterilization temperatures, sterilizing time 20min cools off again, and chilling temperature is 25 ℃.
8, test package:
The cooled product of sterilization through the lamp inspection, is packed warehouse-in.
Embodiment 2
1, the lixiviate of raw material:
1.1 the leaching of safflower effective ingredients: with the safflower suede of purchase carry out selected after, take by weighing 0.4 part and put into the lixiviate jar, add again through 50 parts of the pure water of reverse osmosis water treating equipment, the hot water lixiviate, the hot water temperature is 75-85 ℃, time 70min.
1.2 the lixiviate of black tea active ingredient: with the black tea powder (or instant black tea powder) of buying carry out selected after, take by weighing 0.4 part and put into the lixiviate jar, add again through 50 parts of the pure water of reverse osmosis water treating equipment, the hot water lixiviate, the hot water temperature is 75-85 ℃, time 30min.
2, allotment:
The safflower suede that lixiviate is good, black tea powder liquid and 3 parts of white granulated sugars, 0.1 part of citric acid, 0.04 part of natrium citricum, 0.006 part of saccharin sodium, 0.01 part of acesulfame potassium, vitamin C join in the blend tank for 0.01 part, stir.
3, filter:
After the semi-finished product that allotment is good filtered through diatomite filter, after filtering with Membrane filtering machine, pore size filter was 0.1um again, sends in the surge tank temporary by centrifugal pump.
4, sterilization:
Semi-finished product in the surge tank are gone in the ultra high temperature short time sterilization device to sterilize 125 ℃ of sterilising temps, sterilization time 4s through centrifugal pumping.
5, the sterilization of bottle and lid:
With bottle washing machine bottle and bottle cap are carried out cleaning and sterilizing.
6, filling and sealing:
Adopt WTRO-1 type sterile filling sealing device to carry out filling and sealing, 90 ℃ of can temperature.
7, back sterilization cooling:
Cool off through sterilization behind the fountain sterilization machine again through the product after the can, 85 ℃ of sterilization temperatures, sterilizing time 20min cools off again, and chilling temperature is 28 ℃.
Embodiment 3
1, the lixiviate of raw material:
1.1 the leaching of safflower effective ingredients: with the safflower suede of purchase carry out selected after, take by weighing 0.5 part and put into the lixiviate jar, add again through 50 parts of the pure water of reverse osmosis water treating equipment, the hot water lixiviate, the hot water temperature is 75-85 ℃, time 80min.
1.2 the lixiviate of black tea active ingredient: with the black tea powder (or instant black tea powder) of buying carry out selected after, take by weighing 0.3 part and put into the lixiviate jar, add again through 50 parts of the pure water of reverse osmosis water treating equipment, the hot water lixiviate, the hot water temperature is 75-85 ℃, time 25min.
2, allotment:
The safflower suede that lixiviate is good, black tea powder liquid and 5 parts of white granulated sugars, 0.3 part of citric acid, 0.06 part of natrium citricum, 0.009 part of saccharin sodium, 0.02 part of acesulfame potassium, vitamin C join in the blend tank for 0.02 part, stir.
3, filter:
After the semi-finished product that allotment is good filtered through diatomite filter, after filtering with Membrane filtering machine, pore size filter was 0.5um again, sends in the surge tank temporary by centrifugal pump.
4, sterilization:
Semi-finished product in the surge tank are gone in the ultra high temperature short time sterilization device to sterilize 130 ℃ of sterilising temps, sterilization time 4s through centrifugal pumping.
5, the sterilization of bottle and lid:
With bottle washing machine bottle and bottle cap are carried out cleaning and sterilizing.
6, filling and sealing:
Adopt WTRO-1 type sterile filling sealing device to carry out filling and sealing, 87 ℃ of can temperature.
7, back sterilization cooling:
Cool off through sterilization behind the fountain sterilization machine again through the product after the can, 85 ℃ of sterilization temperatures, sterilizing time 20min cools off again, and chilling temperature is 30 ℃.
Claims (3)
1. safflower tea, it is following to it is characterized by its weight proportion of safflower tea prescription:
100 parts in water
3-5 parts of white granulated sugars
0.2-0.4 part of black tea powder
0.4-0.6 part on safflower
0.1-0.3 part of citric acid
0.04-0.06 part of natrium citricum
0.006-0.009 part of saccharin sodium
Acesulfame potassium 0.01-0.02 part
Vitamin C 0.01-0.02 part.
2. safflower tea according to claim 1, it is following to it is characterized by its weight proportion of safflower tea prescription:
100 parts in water
4 parts of white granulated sugars
0.3 part of black tea powder
0.5 part on safflower
0.2 part of citric acid
0.05 part of natrium citricum
0.008 part of saccharin sodium
0.15 part of acesulfame potassium
0.15 part of vitamin C.
3. the preparation method of safflower tea according to claim 1 and 2, it is following to it is characterized by preparation process:
(1) lixiviate of raw material:
The leaching of safflower effective ingredients: with the purchase safflower suede carry out selected after, put into the lixiviate jar, add the pure water of total water amount 1/2 again; The hot water lixiviate, the hot water temperature is 75-85 ℃, time 60-80min; The lixiviate of black tea active ingredient: with the buying black tea powder carry out selected after, put into the lixiviate jar, add purified water remainder again; The hot water lixiviate, the hot water temperature is 75-85 ℃, time 20-30min;
(2) allotment:
Safflower suede, black tea powder liquid and white granulated sugar, citric acid, natrium citricum, saccharin sodium, acesulfame potassium, vitamin C that lixiviate is good join in the blend tank, stir;
(3) filter:
After the semi-finished product that allotment is good filtered through diatomite filter, after filtering with Membrane filtering machine, pore size filter was 0.1-0.5um again, and is temporary by being pumped in the surge tank;
(4) sterilization:
Semi-finished product in the surge tank are sterilized through being pumped in the sterilizer, and bottle washing machine is to the cleaning and sterilizing of bottle, and said sterilizer is the ultra high temperature short time sterilization device, and said sterilising temp is 120 ℃, 125 ℃ or 130 ℃, and said sterilization time is 4s;
(5) filling and sealing:
Carry out sterile filling and seal, 82-90 ℃ of can temperature;
(6) back sterilization cooling:
Used sterilization machine is the fountain sterilization machine; 85 ℃ of sterilization temperatures, sterilizing time 20min, chilling temperature are 25-30 ℃;
(7) test package:
The cooled product of sterilization through the lamp inspection, is packed warehouse-in.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810000602A CN101480210B (en) | 2008-01-10 | 2008-01-10 | Safflower tea drink and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810000602A CN101480210B (en) | 2008-01-10 | 2008-01-10 | Safflower tea drink and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101480210A CN101480210A (en) | 2009-07-15 |
| CN101480210B true CN101480210B (en) | 2012-10-03 |
Family
ID=40877628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200810000602A Expired - Fee Related CN101480210B (en) | 2008-01-10 | 2008-01-10 | Safflower tea drink and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101480210B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102550748A (en) * | 2010-12-16 | 2012-07-11 | 苏州工业园区尚融科技有限公司 | Preparation method of sugar-free ice black tea beverage by healthy sugar |
| CN105010616B (en) * | 2014-04-29 | 2020-02-11 | 统一企业(中国)投资有限公司昆山研究开发中心 | Lemon-flavor tea beverage product and preparation method thereof |
| CN104621288A (en) * | 2015-02-28 | 2015-05-20 | 今麦郎饮品股份有限公司 | Low-sugar and low-heat ice black tea |
| CN105685300A (en) * | 2016-02-25 | 2016-06-22 | 江苏康缘药业股份有限公司 | Flos carthami puer tea, instant flos carthami puer tea and preparing method of instant flos carthami puer tea |
| CN109287803A (en) * | 2018-11-27 | 2019-02-01 | 上海应用技术大学 | A kind of tawny daylily tea beverage and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1088740A (en) * | 1993-01-01 | 1994-07-06 | 朱利朝 | Beauty tea |
| CN1277809A (en) * | 2000-07-17 | 2000-12-27 | 刘国柱 | Sangxing embryo scented tea, ingredient and making art therefor |
| CN1305747A (en) * | 2001-02-15 | 2001-08-01 | 黄毅 | Red orchid beverage and its preparing process |
| CN1408283A (en) * | 2001-09-22 | 2003-04-09 | 马永军 | Safflower tea |
-
2008
- 2008-01-10 CN CN200810000602A patent/CN101480210B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1088740A (en) * | 1993-01-01 | 1994-07-06 | 朱利朝 | Beauty tea |
| CN1277809A (en) * | 2000-07-17 | 2000-12-27 | 刘国柱 | Sangxing embryo scented tea, ingredient and making art therefor |
| CN1305747A (en) * | 2001-02-15 | 2001-08-01 | 黄毅 | Red orchid beverage and its preparing process |
| CN1408283A (en) * | 2001-09-22 | 2003-04-09 | 马永军 | Safflower tea |
Non-Patent Citations (1)
| Title |
|---|
| JP昭56-123920A 1981.09.29 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101480210A (en) | 2009-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5582519B2 (en) | Mixed tea beverage composition having excellent palatability and method for producing the same | |
| CN103627586B (en) | Health-care glutinous rice wine and preparation method thereof | |
| CN102787062A (en) | Okra and maca wine and preparation method of okra and maca wine | |
| CN101480210B (en) | Safflower tea drink and preparation method thereof | |
| CN105199905B (en) | A kind of preparation method of wax apple fruit wine | |
| CN101502320B (en) | Method for producing ginseng ginger red date drink | |
| CN104256817A (en) | Functional drink with function of relieving visual fatigue and preparation method thereof | |
| WO2017201877A1 (en) | Red yeast grape wine and manufacturing method thereof | |
| CN106497723B (en) | A fruit wine brewed from flos Juglandis, folium Juglandis, lignum seu radix Baphicacanthis Cusiae and Endocarpium Juglandis | |
| CN106551400A (en) | A kind of Cortex Eucommiae anti-fatigue health-caring beverage and preparation method thereof | |
| CN107157850A (en) | A kind of dendrobium candidum eye skin care item and preparation method thereof | |
| CN106118980A (en) | A kind of health care dinner party with singsong girls in attendance with beauty and skin care function | |
| CN106434082A (en) | Method for preparing sulfur-free davidii foex wine | |
| CN104543148A (en) | Preparation method of chrysanthemum, sophora japonica and green tea beverage for improving eyesight | |
| CN111939108A (en) | Kumquat essential oil hydrolat mask and preparation method thereof | |
| CN106497737A (en) | Compound health preserving fruit wine of a kind of Hylocereus undatuss Fructus Mali pumilae and preparation method thereof | |
| CN101310628A (en) | Pawpaw vinegar beverage and preparation method thereof | |
| CN110327369A (en) | A kind of selenium-rich eye refreshing drop and preparation method thereof | |
| CN102687832A (en) | Preparation method of broad bean paste | |
| CN110029031A (en) | A kind of yellow rice wine and preparation method of five cereals and dry fruit brewing | |
| CN108174956A (en) | A kind of anthocyanidin tea prescription and preparation method thereof | |
| CN106360222A (en) | Roselle vinegar beverage with hangover-alleviating health care effect and preparation method thereof | |
| CN112314817A (en) | Preparation method of double-rose pomegranate composite nutritional beverage | |
| CN104839399B (en) | A kind of tealeaves of Soboring-up liver-protecting | |
| CN109362926A (en) | One kind is clear liver and improved vision haw thorn and chrysanthemum tea and its processing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121003 |